Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
January 2004
Features
Biotechnology Update
Advances in Treating Crohn’s Disease, Rheumatoid Arthritis, and Ankylosing Spondylitis: The “Dark Side” of Anti–Tumor Necrosis Factor Therapy
Dr. Goldenberg reviews the risks associated with some biological agents, which had been heralded as a breakthrough in the treatment of certain medical conditions.
Marvin M. Goldenberg, PhD, RPh, MS
A Pharmacist–Physician Antibiotic Support Team
The authors describe a pilot study during which many interventions resulted in a cost savings of more than $124,000 and enhanced patient care.
Timothy R. Pasquale, PharmD, Kenneth M. Komorny, PharmD, BCPS, Dorcas Letting-Mangira, PharmD, and Stephanie Peshek, PharmD
P&T Snapshot
Infliximab Therapy for Crohn’s Disease
The Impact of Implementing Community-Acquired Pneumonia Guidelines in a Rural Hospital
The authors explain how developing new guidelines at one hospital has improved the quality of care and has reduced the length of stay for patients with community-acquired pneumonia.
Paul D. Santos, PharmD, A. Frederick Hartman, MD, MPH, Susan S. Irving, RN, MPH, Sanjay Merchant, PhD, MBA, Brian Meissner, PharmD, Eileen M. Farrelly, MPH, and Kristine M. Floyd, PharmD
Commentary
Evidence: Is There Ever Enough?
Dr. Greengold discusses a moral and intellectual dilemma faced by P&T committees everywhere: deciding when there is enough evidence to add a drug to the formulary.
Nancy L. Greengold, MD, MBA
Drug Safety Revisions: FDA Update
Marvin M. Goldenberg, PhD, RPh, MS
Editorial Board Spotlight
Meet “Marvelous Marvin” Goldenberg
Sonja Sherritze
Departments
Editorial
Countering Counterfeiters
David Nash, MD, MBA, provides some options for countering the problem of counterfeit drugs.
David Nash, MD, MBA
Editor’s Memo
An Editor’s New Year’s Resolutions
Sonja Sherritze presents her modest New Year’s resolutions for P&T.
Sonja Sherritze
Prescription Washington
Major Changes Ahead: Medicare Drug Benefit to Affect the Entire Drug-Distribution Chain
Stephen Barlas discusses the ramifications of the new Medicare prescription drug benefit.
Stephen Barlas
Medication Errors
A Near-Fatal Pediatric Accident: Is It Time to Reassess a Common Cost-Cutting Measure?
Matthew Grissinger, RPh, FASCP, describes a near-fatal accident in a child after a syringe of medication was mistaken for a saline solution because of look-alike labeling.
Matthew Grissinger, RPh, FASCP
New Drugs/Drug News
P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new medical devices.
Drug Forecast
Hydroxyurea in the Treatment of Sickle Cell Anemia
The authors describe the role of hydroxyurea (Droxia®) in the treatment of sickle cell anemia.
